EUDA Health Holdings Ltd (EUDA) stock

EUDANasdaqServices-Health ServicesFiscal year ends December 31Also trades as EUDAW

Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Apr 28, 2026Score 5/30

$15.55−0.25 (-1.58%)

Close on Nov 13, 2026Market cap $29.40MP/E –Yield –

EUDA Health price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

EUDA Health's price to sales ratio was 6.4× on Nov 10, 2026, against 28.9× a year earlier. Over the last 5 years it ranged from 0.8× to 47.5×, with a median of 12.7×.

Price to Sales Ratio at the end of each year

Period	Period end	Value	Change (pts)
2026	Nov 10, 2026	6.4×	−15.0
2025	Dec 31, 2025	21.4×	−21.8
2024	Dec 31, 2024	43.2×	+35.5
2023	Dec 29, 2023	7.7×	+6.8
2022	Dec 30, 2022	0.9×	–

Where these numbers come from

Parsed from the XBRL in EUDA Health's annual and quarterly filings with the SEC
Per-share figures adjusted for the 1-for-20 reverse split on Mar 23, 2026
Fourth quarters derived from the annual report minus nine months
Every figure in the statements links to its source filing

Against peers

Trailing twelve months. Peers are matched on business description, industry and size. Ticks are peers, the dot is EUDA.

Compare: EUDA vs ALPS · EUDA vs ATPC · EUDA vs LDDD · EUDA vs VSEE · EUDA vs MCTA

Revenue growth70.0% · median -20.3%

Gross margin43.9% · median 55.9%

Operating margin-36.3% · median -88.4%

Net margin-40.7% · median -98.9%

Company	Revenue	Growth
VSEE	$12.63M	+10.1%
EUDA	$6.82M	+70.0%
LDDD	$1.82M	-57.2%
ATPC	$1.15M	-20.3%
ALPS	–	–
MCTA	–	–

Company

Exchange: Nasdaq
Industry: Services-Health Services
Fiscal year ends: December 31
Employees: 123
Auditor: Marcum Asia CPAs LLP
SEC CIK: 1847846

Advertisement
300 × 250

See a number that looks wrong?

EUDA Health price to sales ratio

Price to Sales Ratio at the end of each year

More EUDA Health figures